Follow

Attana AB

NGM Nordic SME (Sweden)

Attana specialises in vitro characterization of molecular interactions, which is used for analysis in the development of new pharmaceuticals. The company's patented solutions are mainly used in the study of different binding properties and macrostructures in cells, proteins, viruses, and bacteria.
Go to market

Sector:
HEALTH CARE
>
Healthcare
Medical Diagnostics & Research
Media
Current instruments
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
ATANA
SE0010547273
NGM Nordic SME
Sweden (SE)
Details of share in Attana AB with ticker ATANA
Status
Active
Amount of instruments
209 067 428
Currency
SEK
Segment
Nordic SME Sweden
First trading date
07 Mar 2018
Type
Price
Pre-money
Time
Files
IPO
0.60 SEK
62.56M SEK
09 Nov - 30 Nov 2017
IPO in Attana AB
Type
Price
Pre-money
Time
Files
Rights issue
0.30 SEK
36.53M SEK
20 Aug - 03 Sep 2019
Share issue in Attana AB
Type
Price
Pre-money
Time
Files
Rights issue
1.30 SEK
221.61M SEK
03 Dec - 17 Dec 2020
Share issue in Attana AB
People
Bo Teodor Aastrup
CEO
Jan Arne Gunnar Nabseth
Chairman of the board
Lena Christina Jendeberg
Board member
Gustav Ingemar Kihlström
Board member
Bo Teodor Aastrup
Board member
Jan Arne Gunnar Nabseth
Board member
Company Details
Sector
HEALTH CARE
Website

Address
Greta Arwidssons väg 21
Zip code
114 19
City/district
Stockholm
Country
Sweden (SE)
Phones
Registration number
556931-4106
LEI code
549300KAI93YCW5ISI45
First trade date
07 Mar 2018
Registration date
10 May 2013
Short name
Attana

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More